Document is current
Any future updates will be listed below
-
Authors
Shrivastava, Shikha
Carmen, Joshua M.
Kim, Jiae
Peachman, Kristina K.
Basu, Shraddha
Alving, Ryan
Nettere, Danielle
Kundu, Gautam
Yum, Lauren
Rahman, Mohammad Arif
Jha, Shalini
Trinh, Hung V.
Rosado, Lorean
Nguyen, Phuong
Morrison, Elaine
Swafford, Isabella
Machmach, Kawthar
Bolton, Jessica S.
Yates, Adam
Misicka, Elina
Beck, Zoltan
Mutascio, Simona
Jobe, Ousman
Zemil McCrea, Michelle
Wieczorek, Lindsay
Bergmann-Leitner, Elke S.
Polonis, Victoria
Paquin-Proulx, Dominic
Pollara, Justin
Matyas, Gary R.
Alving, Carl R.
Thomas, Rasmi
Franchini, Genoveffa
Ferrari, Guido
Haynes, Barton F.
Ake, Julie A.
Rao, Mangala
-
Funding
Funding for this research was provided by:
DoD (W81XWH-18-2-0040)
DoD (W81XWH-18-2-0040)
DoD (W81XWH-18-2-0040)
DoD (W81XWH-18-2-0040)
DoD (W81XWH-18-2-0040)
DoD (W81XWH-18-2-0040)
NIAID, NIH
NIH
- License Information
-
More Information
Article History
Received: 23 April 2025
Accepted: 10 November 2025
First Online: 19 December 2025
Competing interests
: C.R.A. and Z.B. are co-inventors on US and International patents for ALFQ. C.R.A. and G.R.M. are co-inventors on a US patent for the use of ALFQ in a malaria vaccine. Both patents are owned by the US Army. The remaining authors declare no competing interests.
